Y. ÜRÜN Et Al. , "ERCC1 as a prognostic factor for survival in patients with advanced urothelial cancer treated with platinium-based chemotherapy: A systematic review and meta-analysis.," Genitourinary Cancers Symposium , vol.33, Florida, United States Of America, 2015
ÜRÜN, Y. Et Al. 2015. ERCC1 as a prognostic factor for survival in patients with advanced urothelial cancer treated with platinium-based chemotherapy: A systematic review and meta-analysis.. Genitourinary Cancers Symposium , (Florida, United States Of America).
ÜRÜN, Y., Leow, J. J., Fay, A. P., Albiges, L., Choueiri, T. K., & Bellmunt, J., (2015). ERCC1 as a prognostic factor for survival in patients with advanced urothelial cancer treated with platinium-based chemotherapy: A systematic review and meta-analysis. . Genitourinary Cancers Symposium, Florida, United States Of America
ÜRÜN, YÜKSEL Et Al. "ERCC1 as a prognostic factor for survival in patients with advanced urothelial cancer treated with platinium-based chemotherapy: A systematic review and meta-analysis.," Genitourinary Cancers Symposium, Florida, United States Of America, 2015
ÜRÜN, YÜKSEL Et Al. "ERCC1 as a prognostic factor for survival in patients with advanced urothelial cancer treated with platinium-based chemotherapy: A systematic review and meta-analysis.." Genitourinary Cancers Symposium , Florida, United States Of America, 2015
ÜRÜN, Y. Et Al. (2015) . "ERCC1 as a prognostic factor for survival in patients with advanced urothelial cancer treated with platinium-based chemotherapy: A systematic review and meta-analysis.." Genitourinary Cancers Symposium , Florida, United States Of America.
@conferencepaper{conferencepaper, author={YÜKSEL ÜRÜN Et Al. }, title={ERCC1 as a prognostic factor for survival in patients with advanced urothelial cancer treated with platinium-based chemotherapy: A systematic review and meta-analysis.}, congress name={Genitourinary Cancers Symposium}, city={Florida}, country={United States Of America}, year={2015}}